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Summary
Munc13-1 is a presynaptic protein that is essential for synaptic vesicle priming. Deletion of Munc13-1/unc13 causes total
arrest of synaptic transmission due to a complete loss of fusion-competent synaptic vesicles. The requirement of
Munc13-1 for large dense-core vesicles (LDCVs), however, has not been established. In the present study, we use
Munc13-1 knockout (KO) and diacylglycerol (DAG) binding-deficient Munc13-1H567K mutant knockin (KI) mice to determine
the role of Munc13-1 in the secretion of insulin-containing LDCVs from primary cultured pancreatic b cells. We show that
Munc13-1 is required for the sustained insulin release upon prolonged stimulation. The sustained release involves signaling
of DAG second messenger, since it is also reduced in KI mice. Insulin secretion in response to glucose stimulation is char-
acterized by a biphasic time course. Our data show that Munc13-1 plays an essential role in the development of the second
phase of insulin secretion by priming insulin-containing LDCVs.Introduction
Insulin release from pancreatic b cells in response to glucose is
characterized by a biphasic time course (Curry et al., 1968). Inter-
estingly, diabetes is associated with disturbance in the biphasic
pattern of insulin secretion, resulting in a blunted first phase and
a diminished second phase (Kahn, 2001). Thus, it is of great im-
portance to understand the mechanisms whereby the biphasic
insulin response is generated and regulated. It has been sug-
gested that the biphasic nature of insulin secretion reflects the
release of spatially and functionally distinct insulin-containing
LDCVs. It is postulated that the first phase of insulin secretion
is attributable to the release of fusion competent LDCVs from
a so-called readily releasable pool (RRP), and the second phase
involves the recruitment of LDCVs to the RRP (Olofsson et al.,
2002; Rorsman and Renstro¨m, 2003). However, as the genera-
tion of biphasic insulin release probably involves concerted
action of multiple factors, the significance of different functional
LDCVs in the contribution of biphasic insulin release under
glucose stimulation remains to be clarified.
Munc13 proteins constitute a family of four mammalian homo-
logs of C. elegans Unc-13 and Drosophila Dunc-13 (Koch et al.,
2000). Genetic deletion of Munc13-1/unc13 causes total arrest
of synaptic transmission due to a complete loss of fusion-com-
petent synaptic vesicles (Augustin et al., 1999; Richmond
et al., 1999). Munc13 proteins contain C2 domain and a DAG
binding C1 domain. The binding of DAG/phorbol-ester to C1 do-
main leads to enhanced priming activity of Munc13-1 (Betz et al.,
1998; Rhee et al., 2002). The requirement of Munc13s for LDCVs,
however, has not been established. Although overexpression of
Munc13-1 has been demonstrated to facilitate the release of
LDCVs in chromaffin cells (Ashery et al., 2000) and pancreaticCELL METABOLISM 3, 463–468, JUNE 2006 ª2006 ELSEVIER INC. DOb cells (Sheu et al., 2003), Munc13-1-deficient chromaffin cells
are found to have normal secretion (Stevens et al., 2005).
Munc13-1 expression level is considerably low in chromaffin
cells (Ashery et al., 2000) but is abundant in b cells (Sheu et al.,
2003). Recently, it has been reported that the levels of
Munc13-1 are severely reduced in pancreatic islets from type 2
diabetic rats (Sheu et al., 2003) as well as in diabetic human islets
(Ostenson et al., 2006). This study is aimed at defining the exact
role of Munc13-1 in insulin secretion.
Results
Isolation of functional pancreatic b cells
from newborn mice
Munc13-1-defecient mice do not feed and can be distinguished
from wild-type (WT) animals shortly after birth by a lack of milk in
their stomachs, weakness, and reduced breathing rate (Augus-
tin et al., 1999). Mutant mice die within a few hours of birth.
Hence, we had to isolate b cells from newborn mice. Islets iso-
lated from pancreas of newborn mice have an average diameter
of 72 6 3 mm (n = 6, see Figure S1 in the Supplemental Data
available with this article online), generally much smaller than
those from adult mice (diameter, 1506 12 mm, n = 7). The num-
ber of islets per pancreas is also smaller in newborn mice. As
a consequence, the yield of pancreatic b cells is consistently
low for newborn mice. It has been noticed that freshly isolated
embryonic or newborn islets usually don’t respond to glucose
and that full glucose-dependent insulin release appears only
during the second day after birth (Bliss and Sharp, 1994; Mene-
ghel-Rozzo et al., 2004). A recent study has demonstrated that
b cells in islet slices from newborn mice progressively gained
the ability to respond to secretagogues after 2 days in cultureI 10.1016/j.cmet.2006.04.012 463
S H O R T A R T I C L E(Meneghel-Rozzo et al., 2004). Consistent with this finding, we
found that isolated b cells from newborn mice apparently devel-
oped typical b cell characteristics including Na+ channel inacti-
vation and response to glucose (see Figure S1) after 3 days in
culture. These results thus open up the possibility for future
functional studies of insulin secretion employing lethal knockout
(KO) mice.
Munc13-1 ablation impairs the sustained component
of exocytosis
To avoid the complications of Ca2+ microdomains associated
with Ca2+ influx and Ca2+ mobilization, exocytosis was elicited
by flash photolysis of caged Ca2+ (Neher, 1998). Exocytosis
was monitored as an increase in the whole-cell membrane ca-
pacitance (Cm). Cm increase in b cells has been mostly ascribed
to the contribution of exocytosis from LDCVs (Braun et al., 2004).
As shown in Figure 1A, the Cm increase in response to step-like
[Ca2+]i elevation starts with an exocytotic burst component
(within 1 s after flash) followed by a linear sustained release in
newborn mouse b cells. It is generally held that the exocytotic
burst represents the release from RRP, and the sustained phase
of secretion is thought to reflect the rate-limiting step of priming
for fusion competence (So¨rensen, 2004; Xu et al., 1998). Detailed
examination of the exocytotic burst revealed a double exponen-
tial time course (inset of Figure 1A), indicating the presence
of two releasable vesicle pools with distinct release kinetics
(So¨rensen, 2004). The exocytotic burst can be best described
by a sum of two exponential components: a fast burst compo-
nent (162.2 6 9.8 fF, n = 24) with a time constant of w50 ms,
and a slow burst component (220.9 6 20.5 fF) with a time
constant ofw500 ms at aroundw20 mM [Ca2+]i. The sustained
componenthasaslope of18.9 fF/s,corresponding toasupplying
rate of 6 granules/s if we assumew3 fF for one insulin-containing
LDCV (Olofsson et al., 2002). The characteristics of these exocy-
totic components were not significantly different from previous
studies on b cells from adult mice (Olofsson et al., 2002; Takaha-
shi et al., 1997).
Similar [Ca2+]i stimulation protocols were applied to b cells
from Munc13-1-deficient mice, which were later confirmed by
PCR genotyping (Augustin et al., 1999). In contrast to the com-
plete loss of fusion-competent synaptic vesicles in Munc13-1
deletion mutants, surprisingly, we found that the burst compo-
nent persists in Munc13-1-deficient b cells. The amplitude of
the fast burst component averages 168.5 6 15.7 fF (n = 17),
which is indistinguishable from that of WT cells. The slow burst
component has an average size of 159.06 33.0 fF and is slightly
smaller than that of WT cells. Importantly, we found that the sus-
tained component was almost abolished in the absence of
Munc13-1, resulting in an 81% inhibition to an average release
rate of 3.6 6 1.4 fF/s. This result indicates that Munc13-1 is
essential for the sustained exocytosis but not required for the
maintenance of the releasable LDCVs.
Munc13-1 deletion retards the recovery of RRP
from depletion
To complement our flash experiments, we further applied paired
trains of depolarization (1 Hz, 10 pulses from270 to 0 mV) to elicit
exocytosis. As shown in Figure 2, a train of depolarization elicits
a Cm increase ofw150 fF, similar to what has been described in
pancreatic b cells (Meneghel-Rozzo et al., 2004; Kanno et al.,
2004). Interestingly, when the cumulative increase in Cm was464compared between WT and KO cells (Figure 2B), we found that
Cm increment during the first two pulses was almost identical,
whereas the responses to the later pulses were significantly re-
duced in the KO cells. We reasoned that the Cm increment during
the first two pulses represents exocytosis from a subset of RRP
close to the Ca2+ channels (Kanno et al., 2004), whereas the later
responses may also include refilling process to the RRP. The
sum of the first two Cm increment recovered after depletion
with a t of 24.8 s (Figure 2C), very similar to that reported previ-
ously (Gromada et al., 1999). Munc13-1 deletion significantly
retarded this recovery in b cells as shown in Figure 2C.
DAG signaling is involved in the development
of the sustained component
Glucose is known to activate intracellular DAG signaling among
many other targets (Nesher et al., 2002). Munc13-1 contains
a DAG/phorbol-ester binding C1 domain and is a potential target
of DAG signaling (Betz et al., 1998). In order to examine the sig-
nificance of the Munc13-1 C1 domain in insulin secretion, we fur-
ther examined LDCV exocytosis in genetically modified mice that
express a mutant Munc13-1H567K variant. The H567K mutation in
Figure 1. Munc13-1 knockout abolishes the sustained release from pancreatic
b cells
A) Averaged [Ca2+]i and Cm responses from WT (n = 24) and Munc13-1 knockout
(KO, n = 17) cells. Inset compares the time course of the exocytotic burst in
expanded time scale.
B) Averaged amplitudes of the exocytotic burst and sustained components for
WT and KO b cells. The Cm response was fitted by triple exponentials and the
amplitudes of the two fast components were taken as the size of the fast burst
and slow burst component, respectively. The release rate of the sustained compo-
nent was quantified by a line fit to the 2–5 s of the Cm trace. Values represent the
mean6 SEM. Asterisks denote significant differences (t test, **p < 0.01) compared
with WT.CELL METABOLISM : JUNE 2006
Role of Munc13-1 in insulin secretionC1 domain abolishes the binding of DAG/phorbol-ester (Betz
et al., 1998). Like Munc13-1 deletion mutants, the homozygous
Munc13-1H567K mutant mice deteriorate rapidly and die within
several hours after birth (Rhee et al., 2002). We found that
Munc13-1H567K knockin (KI) also resulted in a significant block-
ade of the sustained exocytosis from b cells (sustained release
rate, 8.6 6 2.0 fF/s, n = 18, Figure 3), an effect similar to but
less severe than what we observed for the KO mice. Likewise,
the exocytotic burst from KI b cells (fast burst, 153.4 6 14.4 fF;
slow burst, 156.5 6 35.8 fF) was not statistically different from
WT values. Phorbol esters have been shown to augment insulin
secretion from pancreatic b cells (Zawalich et al., 1983; A¨mma¨la¨
et al., 1994). However, the targets of phorbol ester action remain
to be clarified. We examined the consequences of the Munc13-
1H567K mutation on phorbol-12-myristate-13-acetate- (PMA)-
mediated augmentation of exocytosis. We found that application
of 100 nM PMA augmented the Ca2+-stimulated exocytosis in
WT but not KI b cells (Figure 3). We thus conclude that DAG
Figure 2. The recovery of RRP after depletion is retarded in KO cells
A) Example Cm increase elicited by a train of ten 500 ms depolarization pulses
from 270 to 0 mV applied at 1 Hz.
B) Averaged cumulative Cm increments in response to trains of depolarization
pulses from WT (n = 41) and Munc13-1 KO cells (n = 32).
C)Comparison of the recovery of S values between WT and KO cells. Two trains of
depolarization pulses separated by different intervals from 5–120 s were applied to
the same cell. S equals to the Cm increment during the first two pulses as depicted
in (B). The S value from the second train was normalized to that of the first train and
plotted versus time intervals. The time constants of recovery are indicated.CELL METABOLISM : JUNE 2006signaling is involved in the development of the sustained compo-
nent and one of the main targets of PMA in augmenting insulin
secretion is Munc13-1.
Munc13-1 acts upstream of the Ca2+-triggering step
To test whether Munc13-1 acts downstream of priming, we an-
alyzed the kinetics of the exocytotic burst from b cells. As shown
in the inset of Figure 1A, the normalized exocytotic burst from
KO mice is almost identical to that of WT. We further plotted
the individual rate constants of the burst component versus
the postflash [Ca2+]i levels in Figure S2. Clearly, the rate con-
stants and their dependence on [Ca2+]i were indistinguishable
between WT, KO, and KI mice. The steep [Ca2+]i dependence
of the rate constants agrees with previous studies in b cells
(Takahashi et al., 1997). These results indicate that Munc13-1
acts upstream of the Ca2+-triggered fusion step.
Munc13-1 is required for the second phase of insulin
release induced by glucose
To verify whether the phenotype we saw in the Cm signal corre-
lates indeed with insulin secretion, we directly measured the
time course of insulin secretion from isolated islets. The isolated
Figure 3. DAG/phorbol-ester binding C1 domain of Munc13-1 is involved in the
sustained release from pancreatic b cells
A) Averaged [Ca2+]i and Cm responses from WT (n = 24) and KI cells (n = 18), in the
absence and presence of 100 nM PMA (WT + PMA, n = 14; KI + PMA, n = 15).
B) Comparison of the averaged amplitudes of the exocytotic burst and sustained
components, which were calculated as explained in Figure 1. Values represent the
mean 6 SEM. Asterisks denote significant differences (paired t test, **p < 0.01,
*p < 0.05) compared with WT.465
S H O R T A R T I C L Eislets were first bathed in KRBB solution for 1 hr to record the
basal release rate, and then were subjected to 30 min stimula-
tion with glucose (17.5 mM). As shown in Figure 4, glucose stim-
ulation elicited a biphasic insulin secretion typical for mouse
pancreatic islets (Zawalich and Zawalich, 2001). The insulin
release rate per islet is lower than that reported for adult mice
(Zawalich and Zawalich, 2001), perhaps reflecting the fact that
the islets from newborn mice are smaller. Indeed, the insulin
content was measured to be 1.07 ng/islet for newborn mice
and 130.9 ng/islet for adult mice. Interestingly, lack of
Munc13-1 preferentially inhibited the sustained phase of insulin
release by 71%, in contrast to a 34% inhibition in the peak re-
lease rate 2 min after glucose stimulation (Figure 4). It should
be noted that the peak release rate at 2 min should include the
combination of release from both the RRP as well as some of
the refilling LDCVs. As for KI mice, the second phase of insulin
release was impaired to a lesser extent. Consistent with our
Cm measurements, PMA treatment augmented the biphasic
insulin release from WT but not KI mice.
Discussion
In the present study, we determined the role of Munc13-1 in in-
sulin secretion from pancreatic b cells using Munc13-1-deficient
mice and DAG binding-deficient Munc13-1H567K mutant KI
mice. Cm measurements combined with flash photolysis, which
has the advantage of monitoring secretion from the whole pop-
ulation of vesicles with millisecond time resolution, was em-
ployed to assess the exocytosis from different pools of LDCVs.
We found that the sustained component of exocytosis was
almost completely abolished in Munc13-1-deficient b cells,
and to a lesser extent in KI cells. To our surprise, the exocytotic
burst, which represents the releasable vesicles, was not signif-
icantly influenced. One concern of our Cm data is that the reduc-
tion in the sustained component could be due to an increase in
endocytosis. However, this possibility is quite unlikely because:
1) we have directly measured the insulin release and found the
sustained release is indeed reduced in KO/KI cells (Figure 4);
2) the recovery of RRP after depletion, which is unlikely to be
contaminated by endocytosis, is also significantly retarded in
KO cells (Figure 2). We thus conclude that Munc13-1 is required
for the second phase of insulin secretion in response to glucose
stimulation.
Although Munc13-1 is absolutely necessary for neurotrans-
mitter release from synaptic vesicles (Augustin et al., 1999; Rich-
mond et al., 1999), the requirement of Munc13-1 for LDCV exo-
cytosis has not been demonstrated. A recent study in chromaffin
cells, which serves as a perfect model for studying LDCV exocy-
tosis, has revealed that the endogenous Munc13-1 is very low,
and Munc13-1-deficient chromaffin cells have normal LDCV
exocytosis (Stevens et al., 2005). We now show that Munc13-1
is required for sustained insulin secretion from LDCV in pancre-
atic b cells. In contrast to the complete loss of fusion-competent
synaptic vesicles in synapses (Augustin et al., 1999), however,
we found that the releasable LDCVs persist in the Munc13-1-
deficientb cells. This discrepancy can be explained by a different
mechanism in the maintenance of primed vesicles, such that
LDCVs are more stable in the primed state whereas synaptic ves-
icles turnover rapidly in the absence of Munc13-1. It is conceiv-
able that Munc13-1 is required for accelerating (or catalyzing) the
refilling of LDCVs in response to demanding stimulation but not466required for the slow refilling at resting conditions. Alternatively,
other Munc13 isoforms, such as Munc13-2, may compensate
the lack of Munc13-1, although we cannot reliably detect
Munc13-2 expression in pancreatic islets (data not shown).
The mechanism underlying the generation of the biphasic in-
sulin response has been a matter of debate. It has been sug-
gested that the first phase of insulin secretion is attributable to
the release of vesicles from the RRP, while the second phase in-
volves the mobilization and priming of granules from a reserve
pool (Rorsman and Renstro¨m, 2003). This view, however, has
been questioned because the biphasic response to glucose oc-
curs over a lengthy period of time in minutes (Nesher et al.,
2002), whereas the RRP and sustained release happen within
seconds (Olofsson et al., 2002; this study). The generation of bi-
phasic insulin release probably involves a concerted action of
multiple factors, i.e., the time course of glucose input, the wave-
form of [Ca2+]i signals, the generation of second messengers,
the availability of releasable granules and recruitment of gran-
ules, the diffusion of insulin after exocytosis, etc. It is thus very
important to evaluate the relative contribution of different factors
in the production of the biphasic insulin release by specific inter-
ference such as genetic approach (Berggren et al., 2004; Jing
et al., 2005). We now show that genetic ablation of Munc13-1
preferentially abolishes the second phase of insulin response
to glucose as well as the sustained component of exocytosis
measured by Cm increase, providing direct evidence that the
priming of LDCVs from an unprimed pool constitutes a rate-lim-
iting step in the second phase of insulin release.
Nonmetabolic stimuli (e.g., arginine, which is a membrane-
depolarizing agent that promotes Ca2+ influx) elicit only first-
phase insulin response with minimal or no second-phase re-
sponse. Given in combination with a submaximal concentration
of glucose (10 mM), arginine stimulation can produce a biphasic
response (Nesher et al., 2002). Moreover, carbamyl choline
Figure 4. Biphasic insulin response to glucose stimulation from isolated islets
Insulin release was assayed by ELISA and expressed as pg/islet/min. 20 islets from
newborn WT (n = 4), KO (n = 4), and KI (n = 4) mice were manually selected, incu-
bated in KRBB solution for 1 hr, followed by glucose (17.5 mM) stimulation for 30
min. PMA (200 nM) was added 30 min prior to the stimulation and remained
throughout stimulation. Data points were sampled before stimulation (0 min),
and at 2, 5, 15, and 30 min after stimulation. Values represent the mean 6 SEM.
Asterisks denote significant differences (paired t test, *p < 0.05; **p < 0.01)
compared with WT.CELL METABOLISM : JUNE 2006
Role of Munc13-1 in insulin secretion(CCh) produces a biphasic insulin response at substimulatory
glucose levels but no response at all in the absence of glucose
(Nesher et al., 2002). CCh has been shown to recruits Ca2+ via ac-
tivating IP3 and accelerates granule recruitment (Gromada et al.,
1999). These results suggest that metabolic signals (e.g., DAG)
other than the membrane-depolarizing signal are required for
the production (or amplification) of the second phase. Our results
showing that the sustained insulin release is impaired in DAG
binding-deficient Munc13-1H567K KI mice suggest that glu-
cose-activated DAG signaling is involved in the second-phase
insulin response to glucose and that Munc13-1 acts as a key tar-
get of DAG/phorbol-ester. It is interesting that the effect of PMA
is completely abolished in the Munc13-1 KI mice, seemingly to
suggest that PKC activation by PMA plays no role in the control
of exocytosis in mouse b cells. However, an alternative explana-
tion could be that PKC acts upstream of Munc13-1 (Arkhammar
et al., 1994). Also, it should be noted that significant differences
exist between rodent species regarding the responses to glu-
cose and the role of PKC in insulin secretion (Zawalich and Zawa-
lich, 2001). For example, PKC inhibitors staurosporine or GO¨
6976 significantly impaired insulin release in response to glucose
from rat but not mouse islets (Zawalich and Zawalich, 2001). The
conclusive role of PKC in insulin secretion will have to wait for
further detailed studies through combined efforts from genetic
manipulation to integrated physiological analysis.
Experimental procedures
Preparation of newborn mouse pancreatic b Cells and solutions
Munc13-1-deficient and Munc13-1H567K mutant mice were obtained by
interbreeding of animals heterozygous for the Munc13-1 deletion and
Munc13-1H567K mutation, respectively. Mice were routinely genotyped by
PCR as previously described (Augustin et al., 1999; Rhee et al., 2002). Pan-
creas was dissected from newborn mice and placed in filtered KRBB solution
(in mM, 136 NaCl, 4.7 KCl, 1.2 KH2PO4, 5 NaHCO3, 2.5 CaCl2, 1.2 MgSO4, 3
glucose, 10 HEPES, 1 mg/ml BSA, [pH 7.2]). To isolate islets, the gland was
incubated in 4 ml of 1 mg/ml Collagenase V (Sigma C-9263) solution at
37ºC for 5 min, followed by centrifugation after addition of 8 ml KRBB solution.
Pancreatic islets were collected by hand and dissociated to single cells by
digestion with Dispase II (Roche #165859, Mannheim, Germany) and DNase
I (Sigma DN25). Dispersed b cells were kept in DMEM supplemented with 25
mM HEPES, 2 g/L NaHCO3, 100 U/ml penicillin, 100 mg/ml streptomycin and
10% fetal calf serum (Gibco, Grand Island, NY) and used within 3-4 days after
plating.
Standard bath solution for the experiments contained (in mM): 138 NaCl,
5.6 KCl, 1.2 MgCl2, 2.6 CaCl2, 3 Glucose, 5 Hepes (pH 7.2, 310 mosm). Stan-
dard intracellular solution consisted of (in mM): 110 Cs-Glutamate, 2 MgATP,
0.3 GTP, 35 Hepes. For the flash experiments, 5 mM DM-nitrophen (80%
loaded with Ca2+) and 0.2 mM fura-6F were added ([pH 7.2], 300 mosm).
The basal [Ca2+]i was measured to be around 200 nM by fura-2. DM-nitro-
phen, fura-2, fura-2 AM, and fura-6F were purchased from Molecular Probes
(Eugene, Oregon). Unless otherwise stated, all chemicals were from Sigma-
Aldrich (St. Louis, Missouri).
Cm measurement
We selected cells with diameters > 11 mm for study, so that >80%–90% of the
cells were expected to be b cells (Rorsman and Trube, 1986). Occasionally,
the selected cells were validated by their [Ca2+]i response to glucose (see
Figure S1). Conventional whole-cell recordings were performed at 30ºC us-
ing sylgard-coated 3-4 MU pipettes. Series resistances ranged from 4–12
MU were included in the analysis. Cm was measured using an EPC-10
patch-clamp amplifier (HEKA, Lambrecht, Germany) controlled by the
lock-in module of PULSE software, as previously described (Bai et al.,
2006). The capacitance traces were imported to IGOR Pro (WaveMetrics,
Lake Oswego, Oregon) and were analyzed with triple exponential fitting
(Bai et al., 2006). The sustained component of release was measured asCELL METABOLISM : JUNE 2006the slope of Cm increase between 2 and 5 s after each flash. Cm traces
with fast endocytosis (Heinemann et al., 1994) were not included in the
analysis.
Measurements of [Ca2+]i and Photolysis of Caged Ca
2+
Flashes of ultraviolet light and fluorescence-excitation light were generated
as described previously (Xu et al., 1998). In the flash experiments, exocytosis
was elicited by photorelease of caged Ca2+ preloaded into the cell via the
patch pipette. [Ca2+]i was measured with the Ca
2+ indicator dyes fura-2 or
fura-6F. [Ca2+]i was determined from the ratio (R) of the fluorescence signals
excited at the two wavelengths (340/380 nm), following the equation (Grynkie-
wicz et al., 1985): [Ca2+]i = Keff * (R2Rmin)/(Rmax2R), where Keff, Rmin, and
Rmax are constants obtained from intracellular calibration as previously
described (Xu et al., 1998).
ELISA insulin secretion
For assay of insulin release, 20 islets from one animal were preincubated for
60 min at 30ºC in 200 ml KRBB solution (see above). Then a portion of the so-
lution (70 ml) was withdrawn for measuring the basal insulin release. The rest
solution was added to a total volume of 300–400 ml KRBB solution at a final
glucose concentration of 17.5 mM. At each measuring time point (2, 5, 15,
and 30 min.), 70 ml incubation medium was withdrawn for insulin measure-
ment after gentle agitation and was replaced by 70 ml fresh KRBB solution
supplemented with 17.5 mM glucose. All the operation was conducted under
a dissection microscope to avoid damaging islets. Insulin was quantified by
ELISA with commercially available kits according to the manufacturer’s
specifications (Rat/Mouse Insulin ELISA Kit; Linco Research, St. Charles,
Missouri).
Supplemental data
Supplemental data include two figures and http://www.cellmetabolism.org/
cgi/content/full/3/6/463/DC1/.
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